Viracta Therapeutics, Inc.
VIRX
Revenue
120.00k
▼-117.00k▼-49.37%
24 Months ChangeAssets
21.96M
▼-9.36M▼-29.90%
3 Months ChangeLiabilities
28.58M
▼-76.00k▼-0.2653%
3 Months ChangeFree Cash Flow
-11.46M
▼-11.46M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2025-02-05
Form 8-K
ID: 0000950170-25-014630
2025-01-31
Form 8-K
ID: 0000950170-25-011792
2025-01-24
Form 8-K
ID: 0000950170-25-008889
2025-01-17
Form 8-K
ID: 0000950170-25-006711
2024-12-26
Form 8-K
ID: 0000950170-24-140446
2024-11-29
Form 8-K
ID: 0000950170-24-131919
2024-11-22
Form 8-K
ID: 0000950170-24-130294
2024-11-13
Form 10-Q
ID: 0000950170-24-126385
2024-11-13
Form 8-K
ID: 0000950170-24-125937
2024-11-06
Form 8-K
ID: 0000950170-24-122426